Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:1819-1825
Published online before print September 13, 2004, doi: 10.1161/01.CIR.0000142858.44680.27
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
110/13/1819    most recent
01.CIR.0000142858.44680.27v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garnier, A.
Right arrow Articles by Delcayre, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garnier, A.
Right arrow Articles by Delcayre, C.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Animal models of human disease
Right arrow Physiological and pathological control of gene expression
Right arrow Coronary circulation

(Circulation. 2004;110:1819-1825.)
© 2004 American Heart Association, Inc.


Molecular Cardiology

Cardiac Specific Increase in Aldosterone Production Induces Coronary Dysfunction in Aldosterone Synthase–Transgenic Mice

Anne Garnier, PhD*; Jennifer K. Bendall, PhD*; Sebastien Fuchs, MD, PhD; Brigitte Escoubet, MD, PhD; Francesca Rochais, MS; Jacqueline Hoerter, PhD; Johnny Nehme, MS; Marie-Lory Ambroisine, MS; Noeleen De Angelis, PhD; Gilles Morineau, PhD; Pauline d’Estienne, MS; Rodolphe Fischmeister, PhD; Christophe Heymes, PhD; Florence Pinet, PhD; Claude Delcayre, PhD

From INSERM U572, Université Paris 7 (A.G., J.K.B., J.N., M.-L.A., P.D., C.H., C.D.), INSERM U36, Collège de France (S.F.), INSERM U426, CEFI IFR02, Assistance Publique–Hôpitaux de Paris, Faculté de Médecine Bichat (B.E.), and Laboratoire d’hormonologie, Hopital St Louis (G.M.), Paris, France; INSERM U446, Faculté de Pharmacie, Châtenay-Malabry, France (F.R., J.H., R.F.); Instituto Mario Negri, Milano, Italy (N.D.A.); and INSERM U508, Institut Pasteur, Lille, France (F.P.).

Correspondence to Dr Claude Delcayre, INSERM U572, Hôpital Lariboisière, 41 Boulevard de la Chapelle, 75475 Paris cedex 10, France. E-mail claude.delcayre{at}larib.inserm.fr

Received April 7, 2004; revision received July 23, 2004; accepted July 28, 2004.

Background— Elevated circulating aldosterone level is associated with impaired cardiovascular function. Although the mechanisms are not fully understood, aldosterone antagonists decrease total and cardiovascular mortality in heart failure and myocardial infarction. Aldosterone induces cardiac fibrosis in experimental models, and it is synthesized locally in rat heart. These observations suggest pathological effects of aldosterone in heart that remain unclear.

Methods and Results— Transgenic mice (TG) that overexpress the terminal enzyme of aldosterone biosynthesis, aldosterone synthase (AS), in heart have been raised by gene targeting with the {alpha}-myosin heavy chain promoter. AS mRNA increased 100-fold and aldosterone concentration 1.7-fold in hearts of male TG mice relative to wild-type. No structural or myocardial alterations were evidenced, because ventricle/body weight, AT1 and AT2 receptor binding, and collagen content were unchanged in TG. No alteration in cardiac function was evidenced by echocardiography, isolated perfused heart, or whole-cell patch clamp experiments. In contrast, coronary function was impaired, because basal coronary flow was decreased in isolated perfused heart (–55% of baseline values), and vasodilatation to acetylcholine, bradykinin, and sodium nitroprusside was decreased by 75%, 60%, and 75%, respectively, in TG mice compared with wild-type, showing that the defect was not related to NO production.

Conclusions— Increased cardiac aldosterone production in male mice induces a major coronary endothelium-independent dysfunction with no detectable alterations in cardiac structure and function. However, coronary dysfunction may be harmful for coronary adaptation to increased flow demand.


Key Words: aldosterone • hormones • genes • heart diseases




This article has been cited by other articles:


Home page
CirculationHome page
M.-L. Ambroisine, J. Favre, P. Oliviero, C. Rodriguez, J. Gao, C. Thuillez, J.-L. Samuel, V. Richard, and C. Delcayre
Aldosterone-Induced Coronary Dysfunction in Transgenic Mice Involves the Calcium-Activated Potassium (BKCa) Channels of Vascular Smooth Muscle Cells
Circulation, November 20, 2007; 116(21): 2435 - 2443.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P.-A. Arias-Loza, K. Hu, C. Dienesch, A. M. Mehlich, S. Konig, V. Jazbutyte, L. Neyses, C. Hegele-Hartung, K. Heinrich Fritzemeier, and T. Pelzer
Both Estrogen Receptor Subtypes, {alpha} and {beta}, Attenuate Cardiovascular Remodeling in Aldosterone Salt-Treated Rats
Hypertension, August 1, 2007; 50(2): 432 - 438.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Turchin, C. Z. Guo, G. K. Adler, V. Ricchiuti, I. S. Kohane, and G. H. Williams
Effect of Acute Aldosterone Administration on Gene Expression Profile in the Heart
Endocrinology, July 1, 2006; 147(7): 3183 - 3189.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. L. Schiffrin
Effects of Aldosterone on the Vasculature
Hypertension, March 1, 2006; 47(3): 312 - 318.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Vidal, Y. Sun, S. K. Bhattacharya, R. A. Ahokas, I. C. Gerling, and K. T. Weber
Calcium paradox of aldosteronism and the role of the parathyroid glands
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H286 - H294.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Parlakian, C. Charvet, B. Escoubet, M. Mericskay, J. D. Molkentin, G. Gary-Bobo, L. J. De Windt, M.-A. Ludosky, D. Paulin, D. Daegelen, et al.
Temporally Controlled Onset of Dilated Cardiomyopathy Through Disruption of the SRF Gene in Adult Heart
Circulation, November 8, 2005; 112(19): 2930 - 2939.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Quinkler, D. Zehnder, K. S. Eardley, J. Lepenies, A. J. Howie, S. V. Hughes, P. Cockwell, M. Hewison, and P. M. Stewart
Increased Expression of Mineralocorticoid Effector Mechanisms in Kidney Biopsies of Patients With Heavy Proteinuria
Circulation, September 6, 2005; 112(10): 1435 - 1443.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Pitt
A New HOPE for Aldosterone Blockade?
Circulation, September 28, 2004; 110(13): 1714 - 1716.
[Full Text] [PDF]